OGN · ISSUER CIK 1821825
Organon & Co.
Between Aug 1, 2026 and Oct 29, 2026, 2 Organon & Co. insiders reported $0.00 of open-market purchases and $200K of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$200KInsider selling
−$200KNet open-market
Aug 12, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 202613:01 | Aug 11, 2026 | OGN | Head of R&D & CMO | M · Exercise | — | +11,519 | 41,566 | +38% | — | ||
| Aug 12, 202613:01 | Aug 11, 2026 | OGN | Head of R&D & CMO | F · Tax | $13.62 | −4,134 | 37,432 | -10% | $56K | ||
| Aug 5, 202616:04 | Aug 5, 2026 | OGN | Head of Mfg & Supply | S · Sell | $13.57 | −14,761 | 18,475 | -44% | −$200K |